Atacand HCT und Semaglutide Subcutaneous
Bestimmung der Wechselwirkung zwischen Atacand HCT und Semaglutide Subcutaneous sowie der Möglichkeit, beide Arzneimittel gleichzeitig einzunehmen.
In der Datenbank der bei der Entwicklung des Services verwendeten öffentlichen Handbücher wurde eine durch Studienergebnisse statistisch belegte Wechselwirkung nachgewiesen, welche entweder zu den negativen Wirkungen auf die Gesundheit des Patienten führen oder das gemeinsame positive Effekt verstärken kann. Es ist notwendig, einen Arzt zu befragen, um mehrere Arzneimittel gleichzeitig einnehmen zu können.
Konsument:Hydrochlorothiazid kann zu Konflikten mit Blut-glucose-Kontrolle und verringern die Wirksamkeit der semaglutide und anderen Diabetes-Medikamenten. Überwachen Sie Ihre Blutzuckerspiegel eng. Sie müssen möglicherweise eine Dosisanpassung Ihrer Diabetes-Medikamenten während und nach der Behandlung mit Hydrochlorothiazid. Es ist wichtig, Ihren Arzt über alle anderen Medikamente, die Sie verwenden, einschließlich Vitaminen und Kräutern. Hören Sie nicht auf irgendwelche Medikamente, ohne vorher Rücksprache mit Ihrem Arzt.
Fachmann:ÜBERWACHUNG: Die Wirksamkeit von insulin und anderen Antidiabetika kann vermindert werden, indem bestimmte Medikamente, einschließlich der atypischen Neuroleptika, Kortikosteroide, Diuretika, östrogene, gonadotropin-releasing-Hormon-Agonisten, human growth Hormon, Phenothiazine, Gestagene, protease-Hemmer, Sympathomimetika Amine, Hormone der Schilddrüse, L-asparaginase, alpelisib, copanlisib, danazol, Diazoxid, isoniazid, zugenommen, omacetaxine, phenytoin, tagraxofusp, temsirolimus, sowie pharmakologische Dosierungen von Nicotinsäure und adrenocorticotropic Agenten. Diese Medikamente können stören Blutzucker kontrollieren, weil Sie kann dazu führen, Hyperglykämie, Glukose-Intoleranz, neue-onset diabetes mellitus, und/oder Exazerbation eines vorbestehenden diabetes.
MANAGEMENT: Vorsicht ist geboten bei Medikamenten, die stören können Glukose-Stoffwechsel verschrieben, um Patienten mit diabetes. Eine engmaschige klinische überwachung der glykämischen Kontrolle wird empfohlen, nach Beginn oder absetzen dieser Medikamente und die Dosierungen die gleichzeitige Antidiabetika angepasst wie nötig. Patienten sollten darauf hingewiesen werden, Benachrichtigen Ihren Arzt, wenn Ihr Blutzuckerspiegel konstant hoch ist oder wenn Sie erleben die Symptome einer schweren Hyperglykämie, wie übermäßiger Durst und erhöht in der Lautstärke oder Frequenz des wasserlassens. Ebenso sollten die Patienten beobachtet werden, die für Hypoglykämie, wenn diese Medikamente sind zurückgezogen von Ihren therapeutischen Regimes.
- Jori A, Carrara MC "On the mechanism of the hyperglycaemic effect of chlorpromazine." J Pharm Pharmacol 18 (1966): 623-4
- Blayac JP, Ribes G, Buys D, Puech R, Loubatieres-Mariani MM "Effects of a new benzothiadiazine derivative, LN 5330, on insulin secretion." Arch Int Pharmacodyn Ther 253 (1981): 154-63
- "Product Information. Dymelor (acetohexamide)" Lilly, Eli and Company, Indianapolis, IN.
- "Product Information. Elzonris (tagraxofusp)." Stemline Therapeutics, New York, NY.
- "Product Information. Thorazine (chlorpromazine)." SmithKline Beecham, Philadelphia, PA.
- Haiba NA, el-Habashy MA, Said SA, Darwish EA, Abdel-Sayed WS, Nayel SE "Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters." Contraception 39 (1989): 619-32
- "Product Information. Amaryl (glimepiride)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- Stambaugh JE, Tucker DC "Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia." Diabetes 23 (1974): 679-83
- "Product Information. Elspar (asparaginase)." Merck & Co, Inc, West Point, PA.
- Jones IG, Pickens PT "Diabetes mellitus following oral diuretics." Practitioner 199 (1967): 209-10
- "Product Information. Viracept (nelfinavir)." Agouron Pharma Inc, La Jolla, CA.
- Hardy H, Esch LD, Morse GD "Glucose disorders associated with HIV and its drug therapy." Ann Pharmacother 35 (2001): 343-51
- Spellacy WN, Ellingson AB, Tsibris JC "The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use." Fertil Steril 51 (1989): 71-4
- Berlin I "Prazosin, diuretics, and glucose intolerance." Ann Intern Med 119 (1993): 860
- Carter BL, Small RE, Mandel MD, Starkman MT "Phenytoin-induced hyperglycemia." Am J Hosp Pharm 38 (1981): 1508-12
- "Product Information. Starlix (nateglinide)" Novartis Pharmaceuticals, East Hanover, NJ.
- Andersen OO, Persson I "Carbohydrate metabolism during treatment with chlorthalidone and ethacrynic acid." Br Med J 2 (1968): 798-801
- "Product Information. Oncaspar (pegaspargase)." Rhone-Poulenc Rorer, Collegeville, PA.
- Sotaniemi E, Kontturi M, Larmi T "Effect of diethylstilbestrol on blood glucose of prostatic cancer patients." Invest Urol 10 (1973): 438-41
- Al-Rubeaan K, Ryan EA "Phenytoin-induced insulin insensitivity." Diabet Med 8 (1991): 968-70
- Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB, Johnston GD, Bell PM "A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM." Diabetologia 38 (1995): 853-9
- Seltzer HS, Allen EW "Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man." Diabetes 18 (1969): 19-28
- "Product Information. Diabinese (chlorpropamide)." Pfizer US Pharmaceuticals, New York, NY.
- Leary WP, Reyes AJ "Drug interactions with diuretics." S Afr Med J 65 (1984): 455-61
- Petri M, Cumber P, Grimes L, Treby D, Bryant R, Rawlins D, Ising H "The metabolic effects of thiazide therapy in the elderly: a population study." Age Ageing 15 (1986): 151-5
- "Product Information. Glucophage (metformin)." Bristol-Myers Squibb, Princeton, NJ.
- Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R "Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans." Diabetologia 36 (1993): 84-7
- "Product Information. Fortovase (saquinavir)" Roche Laboratories, Nutley, NJ.
- Coni NK, Gordon PW, Mukherjee AP, Read PR "The effect of frusemide and ethacrynic acid on carbohydrate metabolism." Age Ageing 3 (1974): 85-90
- Chaudhuri ML, Catania J "A comparison of the effects of bumetanide (Burinex) and frusemide on carbohydrate metabolism in the elderly." Br J Clin Pract 42 (1988): 427-9
- Black DM, Filak AT "Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection." J Fam Pract 28 (1989): 462-3
- "Product Information. Apidra (insulin glulisine)." Aventis Pharmaceuticals, Bridgewater, NJ.
- "Product Information. Megace (megestrol)." Bristol-Myers Squibb, Princeton, NJ.
- Pickkers P, Schachter M, Hughes AD, Feher MD, Sever PS "Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?" Diabetologia 39 (1996): 861-4
- Erle G, Basso M, Federspil G, Sicolo N, Scandellari C "Effect of chlorpromazine on blood glucose and plasma insulin in man." Eur J Clin Pharmacol 11 (1977): 15-8
- "Product Information. Carafate (sucralfate)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- Schmitz O, Hermansen K, Nielsen OH, Christensen CK, Arnfred J, Hansen HE, Mogensen CE, Orskov H, Beck-Nielsen H "Insulin action in insulin-dependent diabetics after short-term thiazide therapy." Diabetes Care 9 (1986): 631-6
- "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
- "Product Information. Lexiva (fosamprenavir)." GlaxoSmithKline, Research Triangle Park, NC.
- Curtis J, Horrigan F, Ahearn D, Varney R, Sandler SG "Chlorthalidone-induced hyperosmolar hyperglycemic nonketotic coma." JAMA 220 (1972): 1592-3
- Bell DS "Insulin resistance. An often unrecognized problem accompanying chronic medical disorders." Postgrad Med 93 (1993): 99-103,
- "Product Information. Torisel (temsirolimus)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Hyperstat I.V. (diazoxide)." Schering Corp, Kenilworth, NJ.
- Miller NR, Moses H "Transient oculomotor nerve palsy. Association with thiazide-induced glucose intolerance." JAMA 240 (1978): 1887-8
- Kansal PC, Buse J, Buse MG "Thiazide diuretics and control of diabetes mellitus." South Med J 62 (1969): 1372-9
- Dimitriadis G, Tegos C, Golfinopoulou L, Roboti C, Raptis S "Furosemide-induced hyperglycaemia - the implication of glycolytic kinases." Horm Metab Res 25 (1993): 557-9
- "Product Information. Crixivan (indinavir)." Merck & Co, Inc, West Point, PA.
- "Product Information. NovoLog Mix 70/30 (insulin aspart-insulin aspart protamine)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
- Javier Z, Gershberg H, Hulse M "Ovulatory suppressants, estrogens, and carbohydrate metabolism." Metabolism 17 (1968): 443-56
- Charan VD, Desai N, Singh AP, Choudhry VP "Diabetes mellitus and pancreatitis as a complication of L- asparaginase therapy." Indian Pediatr 30 (1993): 809-10
- Goldman JA, Ovadia JL "The effect of estrogen on intravenous glucose tolerance in woman." Am J Obstet Gynecol 103 (1969): 172-8
- Seifer DB, Freedman LN, Cavender JR, Baker RA "Insulin-dependent diabetes mellitus associated with danazol." Am J Obstet Gynecol 162 (1990): 474-5
- "Product Information. Orinase (tolbutamide)" Pharmacia and Upjohn, Kalamazoo, MI.
- "Product Information. Tolinase (tolazamide)" Pharmacia and Upjohn, Kalamazoo, MI.
- Walli R, Demant T "Impaired glucose tolerance and protease inhibitors." Ann Intern Med 129 (1998): 837-8
- Hannaford PC, Kay CR "Oral contraceptives and diabetes mellitus." BMJ 299 (1989): 1315-6
- Mauss S, Wolf E, Jaeger H "Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors." Ann Intern Med 130 (1999): 162-3
- Virutamasen P, Wongsrichanalai C, Tangkeo P, Nitichai Y, Rienprayoon D "Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study." Int J Gynaecol Obstet 24 (1986): 291-6
- Chowdhury FR, Bleicher SJ "Chlorthalidone--induced hypokalemia and abnormal carbohydrate metabolism." Horm Metab Res 2 (1970): 13-6
- Wehring H, Alexander B, Perry PJ "Diabetes mellitus associated with clozapine therapy." Pharmacotherapy 20 (2000): 844-7
- Greenstone MA, Shaw AB "Alternate day corticosteroid causes alternate day hyperglycaemia." Postgrad Med J 63 (1987): 761-4
- Kaufman MB, Simionatto C "A review of protease inhibitor-induced hyperglycemia." Pharmacotherapy 19 (1999): 114-7
- "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc, Rockville, MD.
- "Product Information. Diabeta (glyburide)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- Elmfeldt D, Berglund G, Wedel H, Wilhelmsen L "Incidence and importance of metabolic side-effects during antihypertensive therapy." Acta Med Scand Suppl 672 (1983): 79-83
- Malherbe C, Burrill KC, Levin SR, Karam JH, Forsham PH "Effect of diphenylhydantoin on insulin secretion in man." N Engl J Med 286 (1972): 339-42
- Goldman JA, Neri A, Ovadia J, Eckerling B, Vries A, de "Effect of chlorothiazide on intravenous glucose tolerance in pregnancy." Am J Obstet Gynecol 105 (1969): 556-60
- "Product Information. Agenerase (amprenavir)." Glaxo Wellcome, Research Triangle Pk, NC.
- "Product Information. Zolinza (vorinostat)." Merck & Company Inc, West Point, PA.
- Diamond MT "Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis." N Y State J Med 72 (1972): 1741-2
- "Product Information. Prandin (repaglinide)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
- "Product Information. Precose (acarbose)." Bayer, West Haven, CT.
- Dube MP, Johnson DL, Currier JS, Leedom JM "Protease inhibitor-associated hyperglycaemia." Lancet 350 (1997): 713-4
- "Product Information. Reyataz (atazanavir)." Bristol-Myers Squibb, Princeton, NJ.
- Pollare T, Lithell H, Berne C "A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension." N Engl J Med 321 (1989): 868-73
- Gunnarsson R, Lundgren G, Magnusson G, Ost L, Groth CG "Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient?" Scand J Urol Nephrol Suppl 54 (1980): 135-8
- "Product Information. Glucotrol (glipizide)." Pfizer US Pharmaceuticals, New York, NY.
- Murphy MB, Kohner E, Lewis PJ, Schumer B, Dollery CT "Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up." Lancet 2 (1982): 1293-5
- "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical, Abbott Park, IL.
- "Product Information. Norvir (ritonavir)." Abbott Pharmaceutical, Abbott Park, IL.
- Domenet JG "Diabetogenic effect of oral diuretics." Br Med J 3 (1968): 188
- Rowe P, Mather H "Hyperosmolar non-ketotic diabetes mellitus associated with metolazone." Br Med J 291 (1985): 25-6
- Winchester JF, Kellett RJ, Boddy K, Boyle P, Dargie HJ, Mahaffey ME, Ward DM, Kennedy AC "Metolazone and bendroflumethiazide in hypertension: physiologic and metabolic observations." Clin Pharmacol Ther 28 (1980): 611-8
- Tsiodras S, Mantzoros C, Hammer S, Samore M "Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy - A 5-year cohort study." Arch Intern Med 160 (2000): 2050-6
- "Product Information. Prezista (darunavir)." Ortho Biotech Inc, Bridgewater, NJ.
Generischer Name: candesartan / hydrochlorothiazide
Handelsmarken: Atacand HCT
Synonyme: nein
Generischer Name: semaglutide
Handelsmarken: Ozempic, Rybelsus
Synonyme: Semaglutide
Bei der Prüfung der Kompatibilität und Wechselwirkungen der Arzneimittel werden folgende Handbücher verwendet: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atacand HCT-Semaglutide Tablets
- Atacand HCT-Semprex-D
- Atacand HCT-Semprex-D Oral
- Atacand HCT-Senatec Topical application
- Atacand HCT-Senexon
- Atacand HCT-Senexon-S
- Semaglutide Subcutaneous-Atarax
- Semaglutide Subcutaneous-Atarax (Hydroxyzine Capsules and Tablets)
- Semaglutide Subcutaneous-Atarax (Hydroxyzine Syrup)
- Semaglutide Subcutaneous-Atasol
- Semaglutide Subcutaneous-Atazanavir
- Semaglutide Subcutaneous-Atazanavir and cobicistat